BCDDP Follow Up To Cost $1.6 Million annually For Five Years Okayed; Limited To 59,000 Women
In Brief: NCAB to Hear Report On Treatment Programs, Discuss Hogness Plan For New Type of Review
Clinical Oncology Programs Extended Two Years; No Decision Yet On Further Expansion
NCI T Phase Out Support Of VA Lung Group, But Will Continue Funding VASAG
Three New RFAs Announced In Cancer Control
Trending Stories
- Spending bill passed by the House gives NIH $415M raise, NCI gets $128M
Legislation caps proportion of NIH grants to receive multiyear funding; indirect costs remain untouched - On Day 2 as director of NYU Perlmutter, Anirban Maitra talks about the advantages of running a matrix cancer center
- Supportive cancer care is the smart investment our leaders in Washington can’t afford to ignore
- Abdallah Abou Zahr, an oncologist whose cancer story resonated widely, dies of liposarcoma at 42
- Letai: NCAB’s ad hoc working group plays major role in advising NCI on extramural research
The group replaced the NCI Board of Scientific Advisors - Mail-out colorectal cancer screening programs extend, rather than replace, clinical care









